Remote 24-hour monitoring of cancer patients receiving chemotherapy helps improve the management of side effects and improve quality of life. BMJ today.
Researcher says Remote monitoring We can provide a safe and secure “real-time” system to optimize Symptoms Manage and support patients at home — and especially in the context of the COVID-19 pandemic.
Effective symptom monitoring and management is essential in chemotherapy for cancer, but the current approach relies on the patient’s awareness that the symptom is severe enough and needs to be reported to the care team. doing.
Previous studies of remote monitoring during chemotherapy have shown benefits, but it is difficult to draw broader conclusions because they are based primarily on short-term trials from a single site or country.
To address this gap in evidence, a team of international researchers have found that remote monitoring of chemotherapy-related side effects affects symptomatology burden, supportive care needs, anxiety, work restrictions, and quality of life. We have begun to evaluate the impact.
Their findings are based on 829 patients over the age of 18 who have been diagnosed with breast cancer. Colorectal cancer, Hodgkin’s disease, or non-Hodgkin’s lymphoma, and is receiving chemotherapy at 12 cancer centers in Austria, Greece, Norway, the Republic of Ireland, and the United Kingdom.
Patients were randomly assigned to 24-hour symptom monitoring via the Advanced Symptom Management System (ASyMS) (Intervention group) Or standard treatment at their cancer center (Control group) More than 6 cycles of chemotherapy.
Intervention patients completed a daily symptomatology questionnaire on a handheld ASyMS device. This generated an alert to the hospital clinician when action was needed. Patients were also provided with self-care advice, including information on how to manage their symptoms themselves.
Researchers found that in the intervention group, the burden of symptoms remained at pre-chemotherapy treatment levels, whereas in the control group, an increase after cycle 1 was reported.
Analysis showed a significant decrease in favor of ASyMS for psychological and psychological reasons Physical symptoms And about the level of pain associated with each symptom.
Health-related quality of life scores were high in the intervention group over all cycles, but average anxiety scores were low.
Measures Cancer patientsSelf-confidence and ability to engage in care were also high in the intervention group, and most supportive care needs, including sexual and physical and daily life needs, were low.
The need for supportive care and other areas of work restriction were similar in both groups, and the safety of ASyMS was satisfactory.
This is the largest ever trial of remote monitoring of symptoms during chemotherapy for cancers being treated for therapeutic purposes, and its robust design has circumvented many limitations of previous studies, researchers say. Stated.
They recognize some restrictions, including: Technical problem And the fact that most participants had breast cancer And women, suggesting that patients with other types of cancer need larger studies.
Nonetheless, their findings suggest that evidence-based remote monitoring interventions such as ASyMS have the potential to be implemented in routine care to make a meaningful difference in cancer patients. They say they are.
They add that remote monitoring systems are essential for future services, especially in a mixed model of care delivery that results from the COVID-19 pandemic.
Real-time remote symptomatology monitoring during cancer chemotherapy: European multicenter randomized controlled trial (eSMART) BMJ (2021). DOI: 10.1136 / bmj.n1647 , www.bmj.com/content/374/bmj.n1647
British Medical Journal
Quote: Remote 24-hour monitoring is available for cancer patients obtained on July 21, 2021 from https: //medicalxpress.com/news/2021-07-remote-hour-sizable-positive-effect.html (July 2021) Shows a significant positive effect on (21st)
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
24-hour remote monitoring has shown significant positive effects on cancer patients
Source link 24-hour remote monitoring has shown significant positive effects on cancer patients